HCA Healthcare Statistics
Total Valuation
HCA Healthcare has a market cap or net worth of $98.85 billion. The enterprise value is $150.25 billion.
| Market Cap | 98.85B |
| Enterprise Value | 150.25B |
Important Dates
The last earnings date was Tuesday, October 27, 2026, before market open.
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | Dec 15, 2026 |
Share Statistics
HCA Healthcare has 208.89 million shares outstanding. The number of shares has decreased by -8.70% in one year.
| Current Share Class | 216.50M |
| Shares Outstanding | 208.89M |
| Shares Change (YoY) | -8.70% |
| Shares Change (QoQ) | -2.52% |
| Owned by Insiders (%) | 1.48% |
| Owned by Institutions (%) | 64.51% |
| Float | 144.31M |
Valuation Ratios
The trailing PE ratio is 15.66 and the forward PE ratio is 15.41. HCA Healthcare's PEG ratio is 1.67.
| PE Ratio | 15.66 |
| Forward PE | 15.41 |
| PS Ratio | 1.26 |
| Forward PS | 1.22 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 16.55 |
| P/OCF Ratio | 8.85 |
| PEG Ratio | 1.67 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.52, with an EV/FCF ratio of 25.16.
| EV / Earnings | 22.17 |
| EV / Sales | 1.91 |
| EV / EBITDA | 9.52 |
| EV / EBIT | 12.47 |
| EV / FCF | 25.16 |
Financial Position
The company has a current ratio of 0.82
| Current Ratio | 0.82 |
| Quick Ratio | 0.63 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.12 |
| Debt / FCF | 8.78 |
| Interest Coverage | 5.10 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 12.23% |
| Return on Invested Capital (ROIC) | 21.36% |
| Return on Capital Employed (ROCE) | 27.60% |
| Weighted Average Cost of Capital (WACC) | 8.01% |
| Revenue Per Employee | $245,941 |
| Profits Per Employee | $21,175 |
| Employee Count | 320,000 |
| Asset Turnover | 1.28 |
| Inventory Turnover | 26.47 |
Taxes
In the past 12 months, HCA Healthcare has paid $2.02 billion in taxes.
| Income Tax | 2.02B |
| Effective Tax Rate | 20.60% |
Stock Price Statistics
The stock price has increased by +1.02% in the last 52 weeks. The beta is 1.11, so HCA Healthcare's price volatility has been higher than the market average.
| Beta (5Y) | 1.11 |
| 52-Week Price Change | +1.02% |
| 50-Day Moving Average | 437.41 |
| 200-Day Moving Average | 444.39 |
| Relative Strength Index (RSI) | 60.69 |
| Average Volume (20 Days) | 1,278,538 |
Short Selling Information
The latest short interest is 4.91 million, so 2.35% of the outstanding shares have been sold short.
| Short Interest | 4.91M |
| Short Previous Month | 6.48M |
| Short % of Shares Out | 2.35% |
| Short % of Float | 3.40% |
| Short Ratio (days to cover) | 3.70 |
Income Statement
In the last 12 months, HCA Healthcare had revenue of $78.70 billion and earned $6.78 billion in profits. Earnings per share was $30.22.
| Revenue | 78.70B |
| Gross Profit | 33.65B |
| Operating Income | 12.05B |
| Pretax Income | 9.82B |
| Net Income | 6.78B |
| EBITDA | 15.79B |
| EBIT | 12.05B |
| Earnings Per Share (EPS) | $30.22 |
Balance Sheet
The company has $1.02 billion in cash and $52.43 billion in debt, with a net cash position of -$51.41 billion or -$246.09 per share.
| Cash & Cash Equivalents | 1.02B |
| Total Debt | 52.43B |
| Net Cash | -51.41B |
| Net Cash Per Share | -$246.09 |
| Equity (Book Value) | -4.60B |
| Book Value Per Share | -38.30 |
| Working Capital | -3.56B |
Cash Flow
In the last 12 months, operating cash flow was $11.17 billion and capital expenditures -$5.20 billion, giving a free cash flow of $5.97 billion.
| Operating Cash Flow | 11.17B |
| Capital Expenditures | -5.20B |
| Depreciation & Amortization | 3.74B |
| Net Borrowing | 5.77B |
| Free Cash Flow | 5.97B |
| FCF Per Share | $28.59 |
Margins
Gross margin is 42.76%, with operating and profit margins of 15.31% and 8.61%.
| Gross Margin | 42.76% |
| Operating Margin | 15.31% |
| Pretax Margin | 12.48% |
| Profit Margin | 8.61% |
| EBITDA Margin | 20.06% |
| EBIT Margin | 15.31% |
| FCF Margin | 7.59% |
Dividends & Yields
This stock pays an annual dividend of $3.12, which amounts to a dividend yield of 0.66%.
| Dividend Per Share | $3.12 |
| Dividend Yield | 0.66% |
| Dividend Growth (YoY) | 8.33% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 10.32% |
| FCF Payout Ratio | 10.91% |
| Buyback Yield | 8.70% |
| Shareholder Yield | 9.36% |
| Earnings Yield | 6.39% |
| FCF Yield | 6.04% |
Analyst Forecast
The average price target for HCA Healthcare is $469.91, which is -0.69% lower than the current price. The consensus rating is "Buy".
| Price Target | $469.91 |
| Price Target Difference | -0.69% |
| Analyst Consensus | Buy |
| Analyst Count | 26 |
| Revenue Growth Forecast (3Y) | 4.11% |
| EPS Growth Forecast (3Y) | 7.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HCA Healthcare has an Altman Z-Score of 2.52 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.52 |
| Piotroski F-Score | 6 |